08.03.2011
- Actelion, Europe's largest biotech company, has the backing of Rudolf Maag, one its largest shareholders, a spokeswoman for Maag said on Monday. The company is coming under...
17.02.2011
- French drugmaker Sanofi-Aventis SA agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group's drugs, the...
16.02.2011
- Sanofi-Aventis SA has agreed in principle to acquire Genzyme Corp for $19.2 billion in cash plus future payments based on the performance of an experimental Genzyme drug, according...
14.02.2011
- Sanofi-Aventis, the French drugmaker whose $18.5 billion bid for U.S. biotech Genzyme expires on Tuesday, is studying four acquisitions in the ophthalmology sector, Les Echos...
14.02.2011
- Genzyme Corp investors' confidence that the U.S. biotech is close to an agreement to be taken over by Sanofi-Aventis could be shaken if the French drugmaker extends its tender...
10.02.2011
- Novartis´ generics unit Sandoz is working on eight to 10 new biosimilar molecules to cement its position as leading maker of copycat versions of pricey biotech drugs, the unit's...
07.02.2011
- The boards of Sanofi-Aventis SA and Genzyme Corp were scheduled to hold separate meetings on Sunday to discuss a potential deal, but talks may linger into the week, sources...
03.02.2011
- French drugmaker Sanofi-Aventis could announce a deal to buy U.S. biotech Genzyme early next week if final negotiations between the companies go smoothly, Le Figaro reported on...
02.02.2011
- France's Sanofi-Aventis has agreed to raise its bid for Genzyme Corp to the low $70s-per-share range, plus a milestone payment based on the performance of an experimental drug, a...
01.02.2011
- U.S. biotech Genzyme and French drugmaker Sanofi-Aventis have reached agreement in principle on the terms of a deal under which Sanofi would acquire Genzyme, three sources familiar...
